Bring Regulated Products to Market With Confidence
Regulatory counsel for pharmaceutical, biotechnology, medical device, and compounding pharmacy companies bringing innovative products to market — and keeping them compliant.
The FDA Law Solution advises companies across pharmaceuticals, biologics, medical devices, diagnostics, foods, cosmetics, dietary supplements, consumer products, and compounding pharmacies.
Trusted Across Regulated Industries
Serving companies where regulatory compliance is critical to development, commercialization, and long-term growth.
Pharmaceuticals
Pharmaceuticals
Helping pharmaceutical companies navigate FDA approvals, promotional compliance, inspections, and enforcement risk across the product lifecycle.
Biotechnology
Biotechnology
Advising biotechnology companies on regulatory strategy, clinical development compliance, and commercialization of innovative therapies.
Medical Devices
Medical Devices
Counseling device manufacturers on classification, 510(k) and PMA submissions, quality systems, and post-market regulatory obligations.
Diagnostics
Diagnostics
Guidance for diagnostic companies on regulatory strategy, laboratory compliance, and commercialization of diagnostic technologies.
Food & Beverage
Food & Beverage
Advising companies on food safety regulations, labeling compliance, GRAS determinations, and regulatory risk management.
Dietary Supplements
Dietary Supplements
Counseling supplement companies on formulation, structure-function claims, labeling, and advertising compliance.
Cosmetics & Consumer
Cosmetics & Consumer
Helping cosmetic and consumer product companies navigate evolving regulatory frameworks, labeling requirements, and marketing compliance.
Compounding Pharmacies
Compounding Pharmacies
Regulatory counsel for compounding pharmacies navigating 503A and 503B requirements, GLP-1 therapies, and FDA enforcement risk.
Regulatory Complexity Can Derail Product Success
Companies operating in regulated industries face increasing scrutiny from federal and state authorities. A single compliance failure can delay a launch, trigger a warning letter, or expose the business to enforcement actions.
Strategic Counsel Across the Product Lifecycle
Anticipate regulatory risk, structure compliant pathways, and build operational systems for long-term compliance.
Regulatory Strategy & Classification
Strategic counsel on product classification, regulatory pathways, and market entry planning.
Approvals & Authorizations
Guidance through FDA submission processes and regulatory requirements.
Advertising & Marketing Compliance
Review and compliance for promotional materials, digital marketing, and campaigns.
Enforcement Response
Representation during inspections, warning letters, and enforcement actions.
Post-Market & Recall Strategy
Adverse event reporting, recalls, and post-market surveillance support.
Compliance Systems & Training
Compliance programs, SOPs, training systems, and internal review processes.
Core Practice Areas
Strategic guidance tailored to each category's specific regulatory framework and commercialization risks.
Drugs
Regulatory strategy, approvals, promotional compliance, and enforcement response for pharmaceuticals.
Biological Products
BLA submissions, biosimilar pathways, manufacturing compliance, and post-market requirements.
Medical Devices
Classification, 510(k), PMA submissions, design controls, and post-market surveillance.
Foods
GRAS determinations, labeling compliance, food safety standards, and regulatory strategy.
Cosmetics
MoCRA compliance, ingredient safety, labeling requirements, and marketing compliance.
Dietary Supplements
NDI notifications, labeling, advertising compliance, and cGMP requirements.
Diagnostics & LDTs
Regulatory pathways, laboratory compliance, classification, and commercialization strategy.
GLP-1 Therapies
Regulatory strategy for GLP-1 receptor agonists, FDA compliance, and commercialization pathways.
Specialized Regulatory Expertise
Compounding Pharmacy Regulation
Advising compounding pharmacies and outsourcing facilities on 503A and 503B requirements, state and federal regulatory compliance, product promotion risk, inspection readiness, and enforcement response.
Rare Disease Regulatory Strategy
Strategic counsel for companies developing therapies for rare diseases, including regulatory pathways, product launch readiness, commercialization issues, and post-market compliance considerations.
Building Regulatory-Ready Organizations
Policies, procedures, review systems, and organizational discipline that align internal operations with regulatory requirements.
Led by Experience. Built for Precision.
Ricky C. Benjamin is the founder and managing partner of The FDA Law Solution, LLC. He brings decades of experience across Big Law, in-house general counsel, senior litigation, and FDA regulatory counseling.
He advises product companies on regulatory strategy, product approvals, promotional compliance, enforcement response, and post-market obligations across all major FDA-regulated product categories and compounding pharmacies.
Regulatory Insights
Understanding FDA Warning Letters
A practical guide to responding to FDA warning letters and minimizing enforcement risk.
Read More →02Promotional Review Risks in Digital Marketing
How companies can avoid common compliance pitfalls in digital and social media marketing.
Read More →03503A vs 503B: Compounding Pharmacy Compliance
Key regulatory distinctions between 503A pharmacies and 503B outsourcing facilities.
Read More →04Regulatory Strategy for Rare Disease Launches
Strategic considerations for companies bringing rare disease therapies to market.
Read More →FDA Compliance Checklist
Download a practical checklist to help compliance leaders prepare for launch, promotional review, and ongoing post-market obligations.
Speak With a Regulatory Counselor
If your organization is navigating product approvals, inspections, promotional review, or post-market enforcement issues, strategic regulatory counsel can help you move forward with confidence.
Schedule a ConsultationA short conversation can often uncover compliance risks before regulators do.